Use PRN Olanzapine, Not Quetiapine
For a patient on scheduled olanzapine 20 mg daily who remains psychotic, add PRN olanzapine 2.5-5 mg as needed (up to 2 doses per day), rather than switching to PRN quetiapine 25 mg. This approach maintains therapeutic consistency with the same antipsychotic agent and avoids the complications of polypharmacy with different antipsychotic classes.
Rationale for PRN Olanzapine
The 2018 ESMO guidelines 1 explicitly support using PRN dosing of the same antipsychotic agent already prescribed for scheduled dosing. For olanzapine specifically, they recommend 2.5-5 mg p.o. or s.c. stat for breakthrough symptoms, with the caveat that PRN medications should be used for the shortest period possible and reviewed daily 1.
Key principle: When a patient is already on a scheduled antipsychotic, PRN doses of the same medication are preferred over adding a different antipsychotic. This avoids antipsychotic polypharmacy, which increases side effect burden without clear efficacy advantages 2.
Why Not Quetiapine 25 mg PRN?
Adding quetiapine to scheduled olanzapine creates antipsychotic polypharmacy, which:
- Increases overall side effect risk without proven superior efficacy 2
- Complicates the clinical picture when trying to assess which medication is working or causing adverse effects
- The 25 mg quetiapine dose is subtherapeutic for psychosis (therapeutic range is 400-800 mg/day for schizophrenia per FDA label 3)
- Quetiapine at 25 mg is primarily sedating rather than antipsychotic 4
The 2002 Alzheimer's guidelines 4 note quetiapine is "more sedating" with initial dosing at 12.5 mg twice daily, and the FDA label 3 confirms that for schizophrenia, the therapeutic dose range is 400-800 mg/day, not 25 mg.
Practical Implementation
Start with olanzapine 2.5 mg PRN (lower dose for older/frail patients) and allow up to 5 mg PRN for breakthrough psychotic symptoms 1. The guidelines specify:
- Maximum 2 doses per day as you've proposed is reasonable
- Space doses at least 2-4 hours apart
- Review daily and convert to scheduled dosing if PRN use becomes regular
- Monitor for drowsiness, orthostatic hypotension, and oversedation 1
Critical Safety Warning
Do NOT combine olanzapine with benzodiazepines - the ESMO guidelines 1 explicitly warn that "fatalities have been reported with concurrent use of benzodiazepines with high-dose olanzapine" due to risk of oversedation and respiratory depression. If benzodiazepines are needed, wait at least 2 hours after olanzapine administration 5.
Before Adding PRN Medication
First reassess why the patient remains psychotic on olanzapine 20 mg daily:
- Verify medication adherence (plasma levels if available)
- Check for drug interactions affecting olanzapine metabolism (smoking status, CYP1A2 inducers/inhibitors)
- Rule out substance use (cannabis, stimulants) worsening psychosis
- Confirm adequate trial duration (at least 4 weeks at therapeutic dose per 2025 INTEGRATE guidelines 6)
- Consider whether 20 mg is truly adequate - some patients require higher doses
If the patient has had an adequate trial (4+ weeks, confirmed adherence, therapeutic dose), switching to a different antipsychotic entirely may be more appropriate than adding PRN doses 6. The 2025 INTEGRATE guidelines 6 recommend switching to a pharmacologically different agent (e.g., risperidone, paliperidone, or amisulpride) after first-line failure, rather than augmenting with PRN doses of the same medication.
Alternative Consideration
If the patient truly needs PRN medication for acute agitation rather than persistent psychosis, and the scheduled olanzapine 20 mg is otherwise working, then PRN olanzapine 2.5-5 mg remains the correct choice over quetiapine 25 mg, which provides sedation without meaningful antipsychotic effect at that dose 4, 3.